1. Executive Summary – Global Market
1.1. Market Overview
1.2. Market Analysis
1.3. Fact.MR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Overview
2.1. Market Introduction
2.2. Market Taxonomy
2.3. Market Definition
2.4. Market Scenario
3. Market Dynamics
3.1. Macroeconomic Factors
3.2. Drivers
3.3. Restraints
3.4. Trends
3.5. Opportunity
3.6. Regulatory Scenario
3.7. Reimbursement Scenario
3.8. Hospital Outpatient and ASC Payment – Medicare
3.9. Hospital Inpatient Payment – Medicare
3.10.Key Manufacturer
3.11.Pricing Analysis
3.12.Supply Chain
4. Global Healthcare & Related Sector Outlook
4.1. Global Healthcare Spending, 2023-2033
5. Global Market Analysis and Forecast, Product Type
5.1. Global Market Outlook
5.1.1. Market Value (US$ Mn) Forecast and Analysis
5.1.2. Regional Demand Assessment
5.1.2.1. Market Value Share by Region
5.2. Introduction
5.3. Global Market Analysis and Volume by Product Type
5.3.1. Lithotripsy Devices
5.3.1.1. Intracorporeal Lithotripsy Devices
5.3.1.2. Extracorporeal Lithotripsy Devices
5.3.2. Ureteroscopes
5.3.3. Nephroscopes
5.4. Market Attractiveness Analysis By Product Type
6. Global Market Analysis and Forecast, End User
6.1. Introduction
6.2. Global Market Analysis by End User
6.2.1. Hospitals
6.2.2. Ambulatory Surgical Centers
6.2.3. Specialty Clinics
6.3. Market Attractiveness Analysis By End User
7. Global Market Analysis and Forecast, Region
7.1. Introduction
7.2. Global Market Analysis by Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. CIS & Russia
7.2.5. APEJ
7.2.6. Japan
7.2.7. MEA
7.3. Market Attractiveness Analysis By Region
8. North America Market Analysis
8.1. Introduction
8.1.1. North America Outlook
8.1.1.1. Economic Outlook
8.1.1.2. Business Outlook
8.1.1.3. Political Outlook
8.1.2. North America Healthcare Industry Outlook
8.1.3. North America Market Trend
8.2. North America Market Outlook
8.2.1. Market Value (US$ Mn) and Volume Forecast and Analysis
8.2.2. Country Wise Demand Assessment
8.2.2.1. US Market Value Share and Forecast
8.2.2.2. Canada Market Value Share & Forecast
8.3. North America Market Analysis by Product Type
8.3.1. Lithotripsy Devices
8.3.1.1. Intracorporeal Lithotripsy Devices
8.3.1.2. Extracorporeal Lithotripsy Devices
8.3.2. Ureteroscopes
8.3.3. Nephroscopes
8.4. North America Market Analysis by End User
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Specialty Clinics
8.5. Market Attractiveness Analysis
8.5.1. By Country
8.5.2. By Product Type
8.5.3. By End User
8.6. Drivers and Restraints: Impact Analysis
9. Latin America Market Analysis
9.1. Introduction
9.1.1. Latin America Outlook
9.1.1.1. Economic Outlook
9.1.1.2. Business Outlook
9.1.1.3. Political Outlook
9.1.2. Latin America Healthcare Industry Outlook
9.1.3. Latin America Market Trend
9.2. Latin America Market Outlook
9.2.1. Market Value (US$ Mn) and Volume Forecast and Analysis
9.2.2. Country Wise Demand Assessment
9.2.2.1. Brazil Market Value Share & Forecast
9.2.2.2. Mexico Market Value Share & Forecast
9.2.2.3. Rest of LATAM Market Value Share & Forecast
9.3. Latin America Market Analysis by Product Type
9.3.1. Lithotripsy Devices
9.3.1.1. Intracorporeal Lithotripsy Devices
9.3.1.2. Extracorporeal Lithotripsy Devices
9.3.2. Ureteroscopes
9.3.3. Nephroscopes
9.4. Latin America Market Analysis by End User
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Specialty Clinics
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Product Type
9.5.3. By End User
9.6. Drivers and Restraints: Impact Analysis
10. Europe Market Analysis
10.1. Introduction
10.1.1. Europe Outlook
10.1.1.1. Economic Outlook
10.1.1.2. Business Outlook
10.1.1.3. Political Outlook
10.1.2. Europe Healthcare Industry Outlook
10.1.3. Europe Market Trend
10.2. Europe Market Outlook
10.2.1. Market Value (US$ Mn) and Volume Forecast and Analysis
10.2.2. Country Wise Demand Assessment
10.2.2.1. EU4 Market Value Share & Forecast
10.2.2.2. U.K. Market Value Share & Forecast
10.2.2.3. Eastern Europe Market Value Share & Forecast
10.2.2.4. Rest of Europe Market Value Share & Forecast
10.3. Europe Market Analysis by Product Type
10.3.1. Lithotripsy Devices
10.3.1.1. Intracorporeal Lithotripsy Devices
10.3.1.2. Extracorporeal Lithotripsy Devices
10.3.2. Ureteroscopes
10.3.3. Nephroscopes
10.4. Europe Market Analysis by End User
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialty Clinics
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By End User
10.6. Drivers and Restraints: Impact Analysis
11. CIS & Russia Market Analysis
11.1. Introduction
11.1.1. CIS & Russia Business Outlook
11.1.2. CIS & Russia Healthcare Industry Outlook
11.1.3. CIS & Russia Market Trend
11.2. CIS & Russia Market Outlook
11.2.1. Market Value (US$ Mn) and Volume Forecast and Analysis
11.3. CIS & Russia Market Analysis by Product Type
11.3.1. Lithotripsy Devices
11.3.1.1. Intracorporeal Lithotripsy Devices
11.3.1.2. Extracorporeal Lithotripsy Devices
11.3.2. Ureteroscopes
11.3.3. Nephroscopes
11.4. CIS & Russia Market Analysis by End User
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialty Clinics
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By End User
11.6. Drivers and Restraints: Impact Analysis
12. APEJ Market Analysis and Forecast
12.1. Introduction
12.1.1. APEJ Outlook
12.1.1.1. Economic Outlook
12.1.1.2. Business Outlook
12.1.1.3. Political Outlook
12.1.2. APEJ Healthcare Industry Outlook
12.1.3. APEJ Market Trend
12.2. APEJ Market Outlook
12.2.1. Market Value (US$ Mn) Forecast and Analysis
12.2.2. Country Wise Demand Assessment
12.2.2.1. Greater China Market Value Share & Forecast
12.2.2.2. India Market Value Share & Forecast
12.2.2.3. ASEAN Market Value Share & Forecast
12.2.2.4. Rest of APEJ Market Value Share & Forecast
12.3. APEJ Market Analysis by Product Type
12.3.1. Lithotripsy Devices
12.3.1.1. Intracorporeal Lithotripsy Devices
12.3.1.2. Extracorporeal Lithotripsy Devices
12.3.2. Ureteroscopes
12.3.3. Nephroscopes
12.4. APEJ Market Analysis by End User
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialty Clinics
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By End User
12.6. Drivers and Restraints: Impact Analysis
13. Japan Market Analysis and Forecast
13.1. Introduction
13.1.1. Japan Business Outlook
13.1.2. Japan Healthcare Industry Outlook
13.1.3. Japan Market Trend
13.2. Japan Market Outlook
13.2.1. Market Value (US$ Mn) and Volume Forecast and Analysis
13.3. Japan Market Analysis by Product Type
13.3.1. Lithotripsy Devices
13.3.1.1. Intracorporeal Lithotripsy Devices
13.3.1.2. Extracorporeal Lithotripsy Devices
13.3.2. Ureteroscopes
13.3.3. Nephroscopes
13.4. Japan Market Analysis by End User
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialty Clinics
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End User
13.6. Drivers and Restraints: Impact Analysis
14. MEA Market Analysis and Forecast
14.1. Introduction
14.1.1. MEA Outlook
14.1.1.1. Economic Outlook
14.1.1.2. Business Outlook
14.1.1.3. Political Outlook
14.1.2. MEA Healthcare Industry Outlook
14.1.3. MEA Market Trend
14.2. MEA Market Outlook
14.2.1. Market Value (US$ Mn) Forecast and Analysis
14.2.2. Country Wise Demand Assessment
14.2.2.1. GCC Countries Market Value Share & Forecast
14.2.2.2. South Africa Market Value Share & Forecast
14.2.2.3. Rest of MEA Market Value Share & Forecast
14.3. MEA Market Analysis by Product Type
14.3.1. Lithotripsy Devices
14.3.1.1. Intracorporeal Lithotripsy Devices
14.3.1.2. Extracorporeal Lithotripsy Devices
14.3.2. Ureteroscopes
14.3.3. Nephroscopes
14.4. MEA Market Analysis by End User
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Specialty Clinics
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By End User
14.6. Drivers and Restraints: Impact Analysis
15. Competitive Assessment
15.1. Global Market Competition – a Dashboard View
15.2. Competition Analysis
15.2.1. Company Market Share Analysis of Top 10 Players, By Region
15.3. Key Participants Market Presence (Intensity Mapping) by Region
16. Company Profiles
16.1. Siemens Healthineers AG
16.1.1. Company Overview
16.1.2. Product Overview
16.1.3. Manufacturing facilities Across Globe, 2033
16.1.4. Region Wise Share of Target Product– Company Benchmark
16.1.5. Company Revenue Share, By Sales Channel
16.1.6. Company Revenue Share, By Buyer
16.1.7. Recent Key Developments
16.1.8. Key Market Strategies
16.1.9. Key Financials
16.1.10. SWOT Analysis
16.2. Dornier MedTech (Subsidiary of Accuron MedTech)
16.2.1. Company Overview
16.2.2. Product Overview
16.2.3. Manufacturing facilities Across Globe, 2033
16.2.4. Region Wise Share of Target Product– Company Benchmark
16.2.5. Company Revenue Share, By Sales Channel
16.2.6. Company Revenue Share, By Buyer
16.2.7. Recent Key Developments
16.2.8. Key Market Strategies
16.2.9. Key Financials
16.2.10. SWOT Analysis
16.3. Lumenis Ltd.
16.3.1. Company Overview
16.3.2. Product Overview
16.3.3. Manufacturing facilities Across Globe, 2033
16.3.4. Region Wise Share of Target Product– Company Benchmark
16.3.5. Company Revenue Share, By Sales Channel
16.3.6. Company Revenue Share, By Buyer
16.3.7. Recent Key Developments
16.3.8. Key Market Strategies
16.3.9. Key Financials
16.3.10. SWOT Analysis
16.4. STORZ MEDICAL AG
16.4.1. Company Overview
16.4.2. Product Overview
16.4.3. Manufacturing facilities Across Globe, 2033
16.4.4. Region Wise Share of Target Product– Company Benchmark
16.4.5. Company Revenue Share, By Sales Channel
16.4.6. Company Revenue Share, By Buyer
16.4.7. Recent Key Developments
16.4.8. Key Market Strategies
16.4.9. Key Financials
16.4.10. SWOT Analysis
16.5. Inceler Medikal Co. Ltd.
16.5.1. Company Overview
16.5.2. Product Overview
16.5.3. Manufacturing facilities Across Globe, 2033
16.5.4. Region Wise Share of Target Product– Company Benchmark
16.5.5. Company Revenue Share, By Sales Channel
16.5.6. Company Revenue Share, By Buyer
16.5.7. Recent Key Developments
16.5.8. Key Market Strategies
16.5.9. Key Financials
16.5.10. SWOT Analysis
16.6. DirexGroup
16.6.1. Company Overview
16.6.2. Product Overview
16.6.3. Manufacturing facilities Across Globe, 2033
16.6.4. Region Wise Share of Target Product– Company Benchmark
16.6.5. Company Revenue Share, By Sales Channel
16.6.6. Company Revenue Share, By Buyer
16.6.7. Recent Key Developments
16.6.8. Key Market Strategies
16.6.9. Key Financials
16.6.10. SWOT Analysis
16.7. Medispec Ltd.
16.7.1. Company Overview
16.7.2. Product Overview
16.7.3. Manufacturing facilities Across Globe, 2033
16.7.4. Region Wise Share of Target Product– Company Benchmark
16.7.5. Company Revenue Share, By Sales Channel
16.7.6. Company Revenue Share, By Buyer
16.7.7. Recent Key Developments
16.7.8. Key Market Strategies
16.7.9. Key Financials
16.7.10. SWOT Analysis
16.8. EDAP TMS S.A.
16.8.1. Company Overview
16.8.2. Product Overview
16.8.3. Manufacturing facilities Across Globe, 2033
16.8.4. Region Wise Share of Target Product– Company Benchmark
16.8.5. Company Revenue Share, By Sales Channel
16.8.6. Company Revenue Share, By Buyer
16.8.7. Recent Key Developments
16.8.8. Key Market Strategies
16.8.9. Key Financials
16.8.10. SWOT Analysis
16.9. GEMSS Co., Ltd.
16.9.1. Company Overview
16.9.2. Product Overview
16.9.3. Manufacturing facilities Across Globe, 2033
16.9.4. Region Wise Share of Target Product– Company Benchmark
16.9.5. Company Revenue Share, By Sales Channel
16.9.6. Company Revenue Share, By Buyer
16.9.7. Recent Key Developments
16.9.8. Key Market Strategies
16.9.9. Key Financials
16.9.10. SWOT Analysis
16.10. Richard Wolf GmbH
16.10.1. Company Overview
16.10.2. Product Overview
16.10.3. Manufacturing facilities Across Globe, 2033
16.10.4. Region Wise Share of Target Product– Company Benchmark
16.10.5. Company Revenue Share, By Sales Channel
16.10.6. Company Revenue Share, By Buyer
16.10.7. Recent Key Developments
16.10.8. Key Market Strategies
16.10.9. Key Financials
16.10.10. SWOT Analysis
17. Assumptions and Acronyms Used
18. Research Methodology
Table 01: Global Key Company and Product Mapping (1/4)Table 02: Global Key Company and Product Mapping (2/4)
Table 03: Global Key Company and Product Mapping (3/4)
Table 04: Global Key Company and Product Mapping (4/4)
Table 05: Global Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 06: Global Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 07: Global Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 08: Global Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Region
Table 09: Global Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Region
Table 10: North America Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Country
Table 11: North America Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 12: North America Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 13: North America Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 14: Latin America Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Country
Table 15: Latin America Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 16: Latin America Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 17: Latin America Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 18: Europe Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Country
Table 19: Europe Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 20: Europe Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 21: Europe Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 22: CIS & Russia Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Country
Table 23: CIS & Russia Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 24: CIS & Russia Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 25: CIS & Russia Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 26: APEJ Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Country
Table 27: APEJ Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 28: APEJ Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 29: APEJ Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 30: Japan Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 31: Japan Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 32: Japan Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
Table 33: MEA Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Country
Table 34: MEA Market Value (US$ Mn) 2018-2022 and Forecast 2023-2033, By Product Type
Table 35: MEA Market Volume (Units) 2018-2022 and Forecast 2023-2033, By Product Type
Table 36: MEA Market Size (US$ Mn) 2018-2022 and Forecast 2023-2033, By End User
| ※参考情報 腎臓結石管理デバイスは、腎臓結石の予防や治療を目的とした医療機器や技術を指します。腎臓結石は、腎臓内でのミネラルの沈着によって形成される硬い結晶であり、患者にとって非常に痛みを伴う状態となります。腎臓結石管理には、結石の発生を予防するためのデバイスや、既に形成された結石を破砕・除去するための機器が存在します。 腎臓結石管理デバイスは、大きく分けていくつかの種類があります。まず、体外衝撃波結石破砕装置(ESWL)は、結石を破砕するために使用される最も一般的なデバイスの一つです。高エネルギーの衝撃波を体外から腎臓に向けて発射し、結石を小さな粒子に破砕します。この方法は非侵襲的であり、患者の身体に対する負担が少ないため、多くの患者に適用されている治療法です。 次に、内視鏡的手法を使用するデバイスもあります。経尿道的腎石除去術(URETEROSCOPY)は、尿道から内視鏡を挿入し、直接結石を視認・除去する方法です。この方法では、レーザーや超音波を用いて結石を破砕し、取り除くことができます。また、経皮的腎石摘出術(PCNL)は、大きな結石や複雑なケースに対して行われる手術で、背中から直接腎臓にアクセスし、結石を取り除くことが可能です。 さらに、腎臓結石の予防に関連するデバイスもあります。例えば、尿中の成分をモニタリングすることで、結石のリスクを評価するデバイスや、適切な水分摂取を促すスマートボトルなどが開発されています。これらの器具は、定期的なデータ収集やフィードバックを通して、患者が自分の状態を把握しやすくし、生活習慣の改善を促します。 腎臓結石管理の関連技術としては、画像診断技術も重要です。CTスキャンや超音波検査は、結石の位置や大きさを正確に把握するために使用されます。これにより、最適な治療方法を選択するための情報を提供します。また、AI技術の進化により、画像解析が行われることで、結石の発見や予測がより効率的に行えるようになっています。 さらに、腎臓結石の管理においては、生体内の環境に応じた個別化医療が進展しています。遺伝的要因や生活習慣に基づいて、結石の形成リスクを評価し、個別に最適な治療法や予防策を提示することが可能となっています。また、栄養学的アプローチも重要で、食事の見直しを行うためのプログラムが提供され、患者がより健康的な生活を送る手助けをします。 今後、腎臓結石管理デバイスはさらに進化し、より効果的で安全な治療が実現されると期待されています。新たな材料や技術の研究が進む中、より効果的な結石除去方法や、結石の予防に向けたデバイスの開発が進められています。患者のQOL(生活の質)を向上させ、結石の再発を防ぐためのインターフェースやシステムの導入も考えられ、今後の動向が非常に注目されています。腎臓結石は多くの人々に影響を与える病態であり、その適切な管理は非常に重要です。そのため、この分野でのイノベーションは患者の生活に大きな改善をもたらす可能性があります。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

